Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
---|
03/06/2001 | US6197294 Cells containing recombinant polynucleotides coding for cell surface molecules that, when expressed in the cell, result in rejection of the cell by host cell by host immune system; useful for gene therapy |
03/06/2001 | US6197293 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof |
03/06/2001 | US6197229 Primary emulsion is formed which optionally contains a dna nicking inhibitor in addition to dna with or without buffer, temperature of the primary emulsion is lowered below the freezing point of the aqueous inner phase |
03/06/2001 | US6197069 Adrenomedullin receptor polynucleotides |
03/01/2001 | WO2001014581A2 Hdac4 and hdac5 in the regulation of cardiac gene expression |
03/01/2001 | WO2001014579A2 Compositions and methods for delivery of an agent using attenuated salmonella containing phage |
03/01/2001 | WO2001014564A2 Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
03/01/2001 | WO2001014555A1 Human narcolepsy gene |
03/01/2001 | WO2001014554A1 G protein-coupled receptor expressed in brain |
03/01/2001 | WO2001014551A1 NOVEL bHLH TYPE TRANSCRIPTION FACTOR GENE DEC2 |
03/01/2001 | WO2001014549A1 Gas1 polypeptides |
03/01/2001 | WO2001014546A2 Replication protein a binding transcriptional factor (rbt1) and uses thereof |
03/01/2001 | WO2001014545A1 Pgrp-l polynucleotides, polypeptides, and antibodies |
03/01/2001 | WO2001014536A2 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
03/01/2001 | WO2001014535A2 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-β1,3-N-ACETYLGALACTOSAMINE-α-R/(GlcNAc to GalNAc) β1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3 |
03/01/2001 | WO2001014530A2 Method for growing stem cells |
03/01/2001 | WO2001014523A1 TktA |
03/01/2001 | WO2001014418A2 p193 PROTEINS AND NUCLEIC ACIDS, AND USES THEREOF |
03/01/2001 | WO2001014416A2 Synthetic papillomavirus genes optimized for expression in human cells |
03/01/2001 | WO2001014415A2 Egfh2 genes and gene products |
03/01/2001 | WO2001014414A2 Human abc2 transporter and uses thereof |
03/01/2001 | WO2001014402A1 Antisense modulation of focal adhesion kinase expression |
03/01/2001 | WO2001014400A1 2'-o-acetamido modified monomers and oligomers |
03/01/2001 | WO2001014387A1 28-epirapalogs |
03/01/2001 | WO2001013960A1 Methods for in vivo gene delivery to sites of cartilage damage |
03/01/2001 | WO2001013959A1 Method for knocking out gene expression by covalently binding antisense probes |
03/01/2001 | WO2001013951A1 Chondrogenesis promoters |
03/01/2001 | WO2001013723A1 Charge reversal of polyion complexes |
03/01/2001 | WO2001013714A2 Prostatic cell line and animal model of a prostatic tumor |
03/01/2001 | WO2000078948A3 Cloning, expression and characterisation of a cdna coding for a rat brain gamma-hydroxybutyrate (ghb) receptor |
03/01/2001 | WO2000075365A3 COMPOUNDS AND METHODS TO ENHANCE rAAV TRANSDUCTION |
03/01/2001 | WO2000073449B1 Dna encoding snorf33 receptor |
03/01/2001 | WO2000072885A9 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
03/01/2001 | WO2000071081A3 Methods of diagnosis and treatment of meniere disease |
03/01/2001 | WO2000066619A3 Means and methods for altering the functional properties in eukaryotic cells |
03/01/2001 | WO2000065060A3 Dna sequence and recombinant production of a graminae allergen |
03/01/2001 | WO2000065056A3 NUCLEIC ACIDS ENCODING A mutT DOMAIN-CONTAINING POLYPEPTIDE |
03/01/2001 | WO2000061141A3 Methods and compositions for enhancing delivery of therapeutic agents to tissues |
03/01/2001 | WO2000049168A3 Helper adenovirus / helper-dependent adenovirus vector system based on site-specific recombinase activity |
03/01/2001 | WO2000049162A8 Compositions and methods for non-targeted activation of endogenous genes |
03/01/2001 | WO2000049038A3 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof |
03/01/2001 | WO2000029582A8 Cell surface receptor antigen vaccines |
03/01/2001 | WO1999040214A8 Nucleic acid delivery vehicles |
03/01/2001 | DE19941186A1 Sequenz-spezifische DNA-Rekombination in eukaryotischen Zellen Sequence-specific DNA recombination in eukaryotic cells |
03/01/2001 | CA2383451A1 28-epirapalogs |
03/01/2001 | CA2383371A1 P193 proteins and nucleic acids, and uses thereof |
03/01/2001 | CA2383063A1 Human abc2 transporter and uses thereof |
03/01/2001 | CA2382939A1 Method for growing stem cells |
03/01/2001 | CA2382674A1 Gas1 polypeptides |
03/01/2001 | CA2382204A1 Prostatic cell line and use thereof to obtain an established prostatic cancer in an animal |
03/01/2001 | CA2382146A1 Pgrp-l polynucleotides, polypeptides, and antibodies |
03/01/2001 | CA2382123A1 Novel polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
03/01/2001 | CA2382045A1 Hdac4 and hdac5 in the regulation of cardiac gene expression |
03/01/2001 | CA2381991A1 Synthetic human papillomavirus genes |
03/01/2001 | CA2381755A1 Compositions and methods for delivery of an agent using attenuated salmonella containing phage |
03/01/2001 | CA2377730A1 Replication protein a binding transcriptional factor (rbt1) and uses thereof |
03/01/2001 | CA2376505A1 Human narcolepsy gene |
03/01/2001 | CA2376406A1 G protein-coupled receptor expressed in brain |
03/01/2001 | CA2304453A1 Use of ec-sod for treatment of systemic autoimmune diseases |
02/28/2001 | EP1078639A1 Stable gene preparations |
02/28/2001 | EP1078267A1 Assays, methods and means for modulating e2f activity |
02/28/2001 | EP1078093A1 Vaccines, immunotherapeutics and methods for using the same |
02/28/2001 | EP1078091A2 Gene therapy vectors and their use in antitumour therapy |
02/28/2001 | EP1078079A1 Methods of forming protein-linked lipidic microparticles, and compositions thereof |
02/28/2001 | EP1078077A1 Nucleic acids and proteins from pineapple stem |
02/28/2001 | EP1078076A2 Novel nucleic acids and polypeptides related to a farnesyl-directed endopeptidase |
02/28/2001 | EP1078075A2 Recombinant (alpha)-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
02/28/2001 | EP1078063A2 Basb029polynucleotide(s) and polypeptides from neisseria meningitis |
02/28/2001 | EP1078062A2 Growth-associated protease inhibitor heavy chain precursor |
02/28/2001 | EP1078060A2 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
02/28/2001 | EP1078048A2 Transgenic animals produced by homologous sequence targeting |
02/28/2001 | EP1078000A2 Peptides |
02/28/2001 | EP1077996A1 HUMAN EDG3sb GENE |
02/28/2001 | EP1077991A1 Secreted proteins and polynucleotides encoding them |
02/28/2001 | EP1077728A1 Protection from ionizing irradiation or chemotherapeutic drug damage by in vivo gene therapy |
02/28/2001 | EP0769902A4 Methods for reducing hyperacute rejection of xenografts |
02/28/2001 | CN1285845A VEGI, an inhibitor of angiogenesis and tumor growth |
02/28/2001 | CN1062602C Gene of Chinese Strain herpes simplex virus thymidine knase, and application of same |
02/27/2001 | US6194547 ETS2 repressor factor (ERF) |
02/27/2001 | US6194389 Particle-mediated bombardment of DNA sequences into tissue to induce an immune response |
02/27/2001 | US6194388 Immunomodulatory oligonucleotides |
02/27/2001 | US6194212 Increasing gene expression by transducing eukaryotic cells with retrovirus vector having heterologous gene linked to regulatory sequence and scaffold attachment region of human interferon-beta gene, allowing cells to rest and express gene |
02/27/2001 | US6194206 Use of oligonucleotide telomerase inhibitors to reduce telomere length |
02/27/2001 | US6194191 Method for the production and purification of adenoviral vectors |
02/27/2001 | US6194187 Apoptosis-inducing protein and gene encoding the same |
02/27/2001 | US6194176 Recombinant expression of proteins from secretory cell lines |
02/27/2001 | US6194174 Histidine kinase, 636 HK, of staphylococcus aureus |
02/27/2001 | US6194171 Also vectors, transformed cells; useful for expression in cells for the purposes of identifying agonists or antagonists of ataxin-2-binding protein function |
02/27/2001 | US6194153 Methods for determining risk of developing alzheimer's disease by detecting mutations in the presenilin 1 (PS-1) gene |
02/27/2001 | US6194142 Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2, and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses |
02/27/2001 | US6193980 Replication defective herpes simplex virus comprising heterologous inserts |
02/22/2001 | WO2001013117A2 Proteins, genes and their use for diagnosis and treatment of breast cancer |
02/22/2001 | WO2001012830A1 Adenoviral vectors including dna sequences encoding angiogenic inhibitors |
02/22/2001 | WO2001012818A1 Neutral cerebral-sphingomyelinase |
02/22/2001 | WO2001012815A1 Coxsackie virus-derived vector system for gene transfer |
02/22/2001 | WO2001012811A1 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
02/22/2001 | WO2001012806A2 Odorant-binding human proteins fixing hydrophobic ligands: polypeptides and polynucleotides coding for said polypeptides and uses thereof |
02/22/2001 | WO2001012805A1 Methods for diagnosis and treatment of human diseases including hypertension |
02/22/2001 | WO2001012804A2 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES |
02/22/2001 | WO2001012803A2 Methods and compositions for restoring antibiotic susceptibility in glycopeptide-resistant enterococcus |